GlassScriptPhysician profile
Ye V Liang
NPI 1023275039
$23,361.79
in general payments reported to CMS, 2019-2025
9 companies · $143 in 2025
The $143 reported for 2025 was less than what a typical Neurology (Psychiatry & Neurology) provider received nationally (typical 2025 total: $454).
See the full distribution for Neurology (Psychiatry & Neurology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $255 · 2020: $3,200 · 2021: $15K · 2022: $2,111 · 2023: $1,718 · 2024: $1,368 · 2025: $143.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $2,550 · Food and Beverage: $595 · Education: $85.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $2,550.00 |
| Food and Beverage | $594.53 |
| Education | $85.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Allergan, INC. | $18,359.62 | 2019-2022 | |
| Abbvie INC. | $4,396.19 | 2022-2025 | |
| Ipsen Biopharmaceuticals, INC | $164.83 | 2023-2025 | Dysport |
| Phathom Pharmaceuticals, INC. | $116.02 | 2024 | Voquezna |
| Medtronic USA, INC. | $111.06 | 2019 | |
| Lilly USA, LLC | $94.27 | 2019 | |
| Merz Pharmaceuticals, LLC | $85.00 | 2023 | |
| Alexion Pharmaceuticals, INC. | $18.37 | 2019 | |
| Amneal Pharmaceuticals LLC | $16.43 | 2023 | Lioresal (Baclofen) |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ye Liang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.